28days Repeat Oral Dose Toxicity Test of 'Hyeonggaeyeongyotang' extract in SD Rats

형개련교탕(荊芥連翹湯) 추출물(抽出物)의 SD Rats에서 28일 경구(經口) 반복투여 독성시험

  • An, Hyun-Jue (College of Oriental Medicine, Dept. of Oriental Medical Ophthalmology & Otolaryngology & Dermatology, Daegu Haany University) ;
  • Hwang, Sun-Yi (College of Oriental Medicine, Dept. of Oriental Medical Ophthalmology & Otolaryngology & Dermatology, Daegu Haany University) ;
  • Lee, Jong-Rok (College of Oriental Medicine, Daegu Haany University) ;
  • Kim, Sang-Chan (College of Oriental Medicine,, Development Team for The New Drug of Oriental Medicine (BK21 program) Daegu Haany University) ;
  • Jee, Seon-Young (College of Oriental Medicine, Dept. of Oriental Medical Ophthalmology & Otolaryngology & Dermatology, Daegu Haany University)
  • 안현주 (대구한의대학교 한의과대학, 안이비인후피부과) ;
  • 황순이 (대구한의대학교 한의과대학, 안이비인후피부과) ;
  • 이종록 (대구한의대학교 한의과대학) ;
  • 김상찬 (대구한의대학교 한의과대학, 한방신약개발연구팀(BK21)) ;
  • 지선영 (대구한의대학교 한의과대학, 안이비인후피부과)
  • Published : 2008.06.30

Abstract

HYTE (Hyeonggaeyeongyotang Extract), a polyherbal formula has been used as folk medicine, 28days repeat oral dose toxicity was tested in SD rats according to KFDA Guideline[2005-60]. Methods : In this study, mortality, clinical signs, body weight and gains, food and water consumption, ophthalmologic observation, urinalysis, hematology, serum biochemistry, gross findings, organ weight and histopathological observations were conducted during 28days of dosing periods. Results: 1. No HYTE treatment-related mortalities and clinical signs were detected in all dosing levels tested in male and female rats during the whole experimental periods. 2. No HYTE treatment-related changes on body weight, gains and food consumption were detected in all dosing levels tested in male and female rats during the whole experimental periods except for 2000mg/kg-dosing female groups in which significantly increase of body weight, gains, food and water consumption were detected compared to that of vehicle control in some points. 3. No HYTE treatment-related changes on ophthalmologic examination were detected in all dosing levels tested in male and female rats. 4. No HYTE treatment-related changes on urinalysis were detected in all dosing levels tested in male and female rats except for 2000mg/kg-dosing female groups in which, significantly increase of urine volume and related decrease on the urine specific gravity were detected as secondary effects of increase on the water consumptions not HYTE treatment-related toxicological signs. 5. No HYTE treatment-related changes on hematology were detected in all dosing levels tested in male and female rats except for increases in the total WBC count and lymphocytes of 2000mg/kg-dosing male and female groups with decrease of large unstained cells as pharmacological effects of immune enhancements not HYTE treatment-related toxicological signs. 6. No HYTE treatment-related changes on serum biochemistry were detected in all dosing levels tested in male and female rats. 7. No HYTE treatment-related changes on gross findings, organ weight and histopathology were detected in all dosing levels tested in male and female rats except for 2000mg/kg-dosing male and female groups in which, spleen and thymus organ weights, hypertrophy at gross observation and hyperpalsia of lymphoid cells and follicles at histopathological observation in spleen and thymus were detected as pharmacological effects of immune enhancements not HYTE treatment-related toxicological signs. Conclusions : Based on these results, the NOAEL and MTD of HYTE in SD rats were considered as over 2000mg/kg, respectively at 28days repeat oral dose toxicity test because most of these findings were considered as results of pharmacological effects of immune enhancements not HYTE treatment-related toxicological signs or secondary effects.

Keywords